Inhibition of CYP3A4 metabolism and P-glycoprotein efflux by PTP-112: Evaluation of different P-GP probe substrates

被引：0
|
作者：
Oganesian, A [1 ]
Tran, J [1 ]
Turner, S [1 ]
Talaat, R [1 ]
Leung, L [1 ]
机构：
[1] Wyeth Res, Drug Safety & Metab, Collegeville, PA 19426 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
295
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [1] Effect of PTP-112 on intestinal P-glycoprotein and CYP3A4 activity using modified Caco-2 monolayers
    Oganesian, A
    Tran, J
    Turner, S
    Talaat, R
    Leung, L
    DRUG METABOLISM REVIEWS, 2003, 35 : 67 - 67
  • [2] P-glycoprotein (P-gp) plays a significant role in enhancing intestinal metabolism by cytochrome P450 3A4 (CYP3A4)
    Cummins, CL
    Benet, LZ
    FASEB JOURNAL, 2001, 15 (04): : A548 - A548
  • [3] Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats
    Suzuki, Kei
    Taniyama, Kazuhiro
    Aoyama, Takao
    Watanabe, Yoshiaki
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (03) : 385 - 392
  • [4] Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats
    Kei Suzuki
    Kazuhiro Taniyama
    Takao Aoyama
    Yoshiaki Watanabe
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 385 - 392
  • [5] Effects of P-glycoprotein (P-GP) inhibitors on CYP3A.
    Wandel, C
    Kim, RB
    Kajiji, S
    Guengerich, FP
    Wood, AJJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 206 - 206
  • [6] Effects of atazanavir on P-glycoprotein (P-gp) transport and CYP3A metabolism in vitro
    Perloff, ES
    Duan, SX
    Greenblatt, DJ
    von Moltke, LL
    FASEB JOURNAL, 2005, 19 (04): : A544 - A544
  • [7] Evaluation of the impact of P-glycoprotein (P-gp) drug efflux transporter blockade on the systemic and ocular disposition of P-gp substrate
    Senthilkumari, Srinivasan
    Velpandian, Thirumurthy
    Biswas, Nlhar R.
    Sonalt, Narayanan
    Ghosei, Supriyo
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, 24 (03) : 290 - 300
  • [8] Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: Influence of cell line and modulator concentration on P-GP activity
    Taub, ME
    Podila, L
    Ely, D
    Almeida, I
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (11) : 1679 - 1687
  • [9] Mibefradil is a potent inhibitor of both CYP3A and P-glycoprotein (P-gp).
    Wandel, C
    Kim, RB
    Guengerich, FP
    Wood, AJJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 124 - 124
  • [10] The consequence of regional gradients of P-gp and CYP3A4 for drug-drug interactions by P-gp inhibitors and the P-gp/CYP3A4 interplay in the human intestine ex vivo
    Li, Ming
    de Graaf, Inge A. M.
    van de Steeg, Evita
    de Jager, Marina H.
    Groothuis, Geny M. M.
    TOXICOLOGY IN VITRO, 2017, 40 : 26 - 33
12345